All patients had symptoms of heart failure (NYHA class II: 5/17, 29%; class III: 9/17, 53%; class IV: 3/17, 18%) and elevated levels of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) (Table 1). The gene discussed is NPPB; the disease is heart failure.